Litcius/Paper detail

Effect of carvedilol versus placebo on cardiac function in anthracycline-exposed survivors of childhood cancer (PREVENT-HF): a randomised, controlled, phase 2b trial

Saro H. Armenian, Melissa M. Hudson, Lanie Lindenfeld, Sitong Chen, Eric J. Chow, Steven D. Colan, Willem Collier, Xiaohong Su, Edward Marcus, Meagan Echevarria, Aleksi Iukuridze, Leslie L. Robison, F. Lennie Wong, Ming Hui Chen, Smita Bhatia

2024The Lancet Oncology34 citationsDOIOpen Access PDF

Topics & Concepts

CarvedilolMedicineHeart failureEjection fractionPlaceboClinical endpointAnthracyclineInternal medicineCancerCardiac function curveRandomized controlled trialCardiologyBreast cancerPathologyAlternative medicineChemotherapy-induced cardiotoxicity and mitigationLung Cancer Research StudiesChildhood Cancer Survivors' Quality of Life
Effect of carvedilol versus placebo on cardiac function in anthracycline-exposed survivors of childhood cancer (PREVENT-HF): a randomised, controlled, phase 2b trial | Litcius